Close Modal AI and the Future of Cancer Treatments A Reno Family Foundation SymposiumJoin us for an inspiring evening with Dr. Sophia Shalhout, a trailblazing cancer researcher who is harnessing the power of artificial intelligence to revolutionize cancer treatment and drug discovery. Sophia Shalhout, PhD, is an Assistant Professor of Otolaryngology – Head and Neck Surgery at Harvard Medical School and a Principal Investigator at the Mike Toth Cancer Research Center at Mass Eye and Ear. Her groundbreaking research applies AI and big data analytics to complex biomedical data, with the goal of advancing personalized medicine for high-risk cancer patients.Dr. Shalhout’s work goes beyond improving individual treatment plans- she is also using AI to accelerate the discovery of new therapies that target some of the most challenging, traditionally "undruggable" cancer proteins. By optimizing molecular interactions and drug-like properties, her approach merges computational biology with lab-based validation, opening doors to entirely new treatment options for deadly cancers.Through presentation and conversation, Dr. Shalhout will share how these powerful technologies are reshaping the landscape of cancer care- from precision medicine to faster, smarter drug development.Don’t miss this opportunity to hear firsthand from one of the leading minds at the intersection of AI and oncology- where innovation meets impact. Register for the Event Date and Time Thursday, May 28 | 7:00pm Audience Adults 18+ Location Blue Wing View Map Price Free with Pre-Registration Language English Register for the Event Date and Time Thursday, May 28 | 7:00pm Audience Adults 18+ Location Blue Wing View Map Price Free with Pre-Registration Language English Sophia Shalhout, PhD, is an Assistant Professor of Otolaryngology – Head and Neck Surgery at Harvard Medical School and a Principal Investigator at the Mike Toth Cancer Research Center at Mass Eye and Ear. Her groundbreaking research applies AI and big data analytics to complex biomedical data, with the goal of advancing personalized medicine for high-risk cancer patients.Dr. Shalhout’s work goes beyond improving individual treatment plans- she is also using AI to accelerate the discovery of new therapies that target some of the most challenging, traditionally "undruggable" cancer proteins. By optimizing molecular interactions and drug-like properties, her approach merges computational biology with lab-based validation, opening doors to entirely new treatment options for deadly cancers.Through presentation and conversation, Dr. Shalhout will share how these powerful technologies are reshaping the landscape of cancer care- from precision medicine to faster, smarter drug development.Don’t miss this opportunity to hear firsthand from one of the leading minds at the intersection of AI and oncology- where innovation meets impact. Featuring Sophia Shalhout, PhD Sophia Shalhout, PhD, is an Assistant Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School and a Principal Investigator, Assistant Professor in the Mike Toth Cancer Research Center at Mass Eye and Ear. Dr. Shalhout’s research focuses on applying novel artificial intelligence (AI) and big data analytics to multi-scale biomedical clinical data. This research aims to advance personalized medicine for high-risk cancer patients. In addition, Dr. Shalhout also leverages AI to discover novel cancer therapies and treatments targeting traditionally undruggable proteins by optimizing drug-like properties and molecular interactions, significantly accelerating the drug discovery process. Her innovative approach bridges computational biology with experimental validation to overcome the limitations of conventional drug discovery and provide new treatment options for deadly cancers. Image Ari Daniel Ari Daniel is an independent science reporter who contributes regularly to National Public Radio among other outlets. He has always been drawn to science and the natural world. As a graduate student, he trained gray seal pups (Halichoerus grypus) for his Master's degree in animal behavior at the University of St. Andrews, and helped tag wild Norwegian killer whales (Orcinus orca) for his Ph.D. in biological oceanography at MIT and the Woods Hole Oceanographic Institution. For more than a decade, as a science reporter and multimedia producer, he has interviewed a species he's better equipped to understand — Homo sapiens.Over the years, Ari has reported across six continents on science topics ranging from astronomy to zooxanthellae. His radio pieces have aired on NPR, The World, Radiolab and Here & Now, and he contributes stories to the New York Times. He formerly worked as Senior Digital Producer at NOVA where he helped oversee the production of the show's digital video content. He is a co-recipient of the AAAS Kavli Science Journalism Gold Award for his radio stories on glaciers and climate change in Greenland and Iceland.In the fifth grade, he won the "Most Contagious Smile" award.
